Twist Bioscience Corporation
TWST
$120.16
-$5.14-4.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.05M | -44.02M | -30.51M | -27.14M | 20.39M |
| Total Depreciation and Amortization | 6.48M | 6.21M | 5.89M | 3.90M | 5.77M |
| Total Amortization of Deferred Charges | 300.00K | 200.00K | 300.00K | 2.10M | 300.00K |
| Total Other Non-Cash Items | 18.34M | 18.44M | 12.94M | 16.30M | -31.64M |
| Change in Net Operating Assets | 11.05M | 1.61M | -13.44M | -6.98M | 3.78M |
| Cash from Operations | 1.12M | -17.56M | -24.81M | -11.81M | -1.40M |
| Capital Expenditure | -9.76M | -7.89M | -9.97M | -12.43M | -9.17M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 0.00 | 2.50M |
| Other Investing Activities | -435.00K | -4.82M | 41.00K | 24.00K | -2.73M |
| Cash from Investing | -10.20M | -12.71M | -9.93M | -12.40M | -9.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.79M | 4.15M | 300.00K | 5.58M | 1.83M |
| Repurchase of Common Stock | -6.00K | -8.00K | -2.00K | -2.00K | -3.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 3.79M | 4.14M | 298.00K | 5.57M | 1.83M |
| Foreign Exchange rate Adjustments | 10.00K | -6.00K | 9.00K | 163.00K | -71.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.29M | -26.13M | -34.44M | -18.48M | -9.04M |